share_log

BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target

BMO Capital Downgrades Sabra Health Care REIT to Market Perform, Announces $16 Price Target

BMO Capital将Sabra Health Care REIT的评级下调至市场表现,宣布目标股价为16美元
Benzinga ·  2023/10/17 07:19

BMO Capital analyst John Kim downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Outperform to Market Perform and announces $16 price target.

蒙特利尔银行资本分析师John Kim将Sabra Health Care REIT(纳斯达克:SBRA)的评级从表现优于大盘下调至市场表现,并宣布16美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发